A detailed history of Stokes Family Office, LLC transactions in Danaher Corp stock. As of the latest transaction made, Stokes Family Office, LLC holds 2,352 shares of DHR stock, worth $571,112. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,352
Previous 2,225 5.71%
Holding current value
$571,112
Previous $555,000 5.77%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$235.51 - $267.98 $29,909 - $34,033
127 Added 5.71%
2,352 $587,000
Q4 2023

Feb 06, 2024

BUY
$185.1 - $233.13 $30,541 - $38,466
165 Added 8.01%
2,225 $514,000
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $480,144 - $547,115
2,060 New
2,060 $511,000
Q3 2022

Nov 10, 2022

SELL
$247.06 - $1507.4 $8,894 - $54,266
-36 Reduced 4.08%
846 $219,000
Q2 2022

Aug 05, 2022

BUY
$237.11 - $299.66 $209,131 - $264,300
882 New
882 $224,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Stokes Family Office, LLC Portfolio

Follow Stokes Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.